Dezhan HealthCare Co Ltd
SZSE:000813
Dezhan HealthCare Co Ltd
Interest Income Expense
Dezhan HealthCare Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dezhan HealthCare Co Ltd
SZSE:000813
|
Interest Income Expense
¥145.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Interest Income Expense
-¥20.1m
|
CAGR 3-Years
-107%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Dezhan HealthCare Co Ltd's Interest Income Expense?
Interest Income Expense
145.8m
CNY
Based on the financial report for Mar 31, 2024, Dezhan HealthCare Co Ltd's Interest Income Expense amounts to 145.8m CNY.
What is Dezhan HealthCare Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
50%
Over the last year, the Interest Income Expense growth was 78%. The average annual Interest Income Expense growth rates for Dezhan HealthCare Co Ltd have been 12% over the past three years , 50% over the past five years .